Loading resource…

Infectious Diseases Institute, College of Health Sciences, Makerere University, Uganda
The document details the transition of patients from efavirenz or nevirapine to a DTG-based first-line regimen as part of Uganda's Ministry of Health guidelines. It highlights the emergence of hyperglycemia cases post-DTG initiation, providing a summary of patient demographics, treatment history, and clinical outcomes. The data reflects the experiences at the Infectious Diseases Institute, which was among the early adopters of DTG in Uganda.
No account needed